Patents/Assignees

Sparx Bioscience Limited

2 patents in portfolio

US12460005utility2025
Binding Molecules Specific for Claudin 18.2, Compositions and Methods Thereof, for Treatment of Cancer and Other Diseases
0 cites
US11970533utility2024
Bispecific Antibodies Targeting Human Claudin 18.2 and Programmed Death-ligand 1 (PD-L1)
0 cites